Nwe Ni Than

904 total citations
25 papers, 664 citations indexed

About

Nwe Ni Than is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Nwe Ni Than has authored 25 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Nwe Ni Than's work include Liver Disease Diagnosis and Treatment (16 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (5 papers). Nwe Ni Than is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (5 papers). Nwe Ni Than collaborates with scholars based in United Kingdom, Germany and Greece. Nwe Ni Than's co-authors include Philip N. Newsome, Ye Htun Oo, James Neuberger, Christoph Schramm, Ansgar W. Lohse, Christina Weiler‐Normann, James Hodson, David Adams, Peter Hübener and Hannah C. Jeffery and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and International Journal of Molecular Sciences.

In The Last Decade

Nwe Ni Than

21 papers receiving 646 citations

Peers

Countries citing papers authored by Nwe Ni Than

Since Specialization

Citations

This map shows the geographic impact of Nwe Ni Than's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nwe Ni Than with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nwe Ni Than more than expected).

Fields of papers citing papers by Nwe Ni Than

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nwe Ni Than. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nwe Ni Than. The network helps show where Nwe Ni Than may publish in the future.

Co-authorship network of co-authors of Nwe Ni Than

This figure shows the co-authorship network connecting the top 25 collaborators of Nwe Ni Than. A scholar is included among the top collaborators of Nwe Ni Than based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nwe Ni Than. Nwe Ni Than is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review 2025 ·International Journal of Molecular Sciences ·(unknown), Chris Kite, (unknown), (unknown), Kamaljit Chatha, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal Randeva	0
2	Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Chris Kite, (unknown), (unknown), Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal Randeva	7
3	Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis 2025 ·Frontiers in Endocrinology ·(unknown), (unknown), Chris Kite, (unknown), (unknown), Nwe Ni Than, Eva Kassi, Harpal Randeva, Ioannis Kyrou	0
4	Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A General Overview and Approach in Clinical Practice 2023 ·Medical Research Archives ·Nwe Ni Than	1
5	The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study 2023 ·JMIR Research Protocols ·(unknown), Ayman Bannaga, Neil Fisher, (unknown), Peter Kimani, (unknown), (unknown), (unknown), Megan P. Hitchins, (unknown), (unknown), Matthew Brookes, Harpal Randeva, Nwe Ni Than, Ramesh Arasaradnam	1
6	An Unusual Case of Hematochezia 2020 ·Cureus ·A. V. Payne, Nwe Ni Than, Rajiv Jalan, Dominic Yu	1
7	Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group 2019 ·JHEP Reports ·Nwe Ni Than, James Hodson, (unknown), Richard Taubert, (unknown), (unknown), (unknown), (unknown), Rebecca Jones, (unknown), Andrew Godkin, Aldo J. Montaño‐Loza, Frank Lammert, Christoph Schramm, Michael P. Manns, Mark G. Swain, Kelly W. Burak, David Adams, Gideon M. Hirschfield, Ye Htun Oo	65
8	Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis 2017 ·Gastroenterology ·Andrew King, Diarmaid D. Houlihan, Dean Kavanagh, Debashis Haldar, (unknown), Andrew Owen, Shankar Suresh, Nwe Ni Than, Gary Reynolds, (unknown), (unknown), Prakash Ramachandran, Neil C. Henderson, Neena Kalia, Jon Frampton, David Adams, Philip N. Newsome	48
9	Title:Successful removal of multiple long foreign bodies: An unusual neck hyperextension technique 2017 ·QJM ·(unknown), Nwe Ni Than, Byron Theron, I Mohammed	0
10	Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients 2016 ·Hepatology International ·Nwe Ni Than, (unknown), James Hodson, (unknown), Jake P. Mann, (unknown), (unknown), Jing Hieng Ngu, Ye Htun Oo	6
11	Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol 2016 ·Systematic Reviews ·Nwe Ni Than, Claire L Tomlinson, Debashis Haldar, Andrew King, David Moore, Philip N. Newsome	13
12	Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease 2016 ·QJM ·Nwe Ni Than, (unknown), James Hodson, Nadeem Tehami, C. Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N. Newsome, Helen L. Reeves, Shishir Shetty	40
13	REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial 2015 ·BMJ Open ·Andrew King, Darren Barton, (unknown), Nwe Ni Than, Joanna Moore, Christopher Corbett, James A. Thomas, (unknown), Indra Neil Guha, Daniel Hollyman, Deborah Stocken, Christina Yap, Richard Fox, Stuart J. Forbes, Philip N. Newsome	27
14	Non-alcoholic fatty liver disease: when to intervene and with what 2015 ·Clinical Medicine ·Nwe Ni Than, Philip N. Newsome	16
15	Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy 2015 ·Scandinavian Journal of Gastroenterology ·Nwe Ni Than, Christiane Wiegard, Christina Weiler‐Normann, (unknown), Jake P. Mann, James Hodson, Gideon M. Hirschfield, Ansgar W. Lohse, David Adams, Christoph Schramm, Ye Htun Oo	39
16	Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance 2015 ·Clinical Gastroenterology and Hepatology ·(unknown), Ye Htun Oo, Nwe Ni Than, Peter Hübener, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm	67
17	A Concise Review of Autoimmune Liver Diseases 2015 ·InTech eBooks ·Nwe Ni Than, Ye Htun Oo	3
18	A concise review of non-alcoholic fatty liver disease 2015 ·Atherosclerosis ·Nwe Ni Than, Philip N. Newsome	234
19	Stem cells for liver regeneration 2014 ·QJM ·Nwe Ni Than, Philip N. Newsome	18
20	Liver abnormalities in pregnancy 2013 ·Best Practice & Research Clinical Gastroenterology ·Nwe Ni Than, James Neuberger	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact